Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386615 · ClinicalTrials.gov registry record
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
A clinical trial of Uterine Fibroid, sponsored by InSightec.
- Recruiting
- Registry status
- 200
- Enrollment target
- 6
- Study locations
NCT05386615: Recruiting study of Uterine Fibroid, sponsored by InSightec.
NCT05386615 is a study of Uterine Fibroid that is actively recruiting participants, run by InSightec. The registered enrollment target is 200 participants, below the 282-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (29% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05386615, a study of Uterine Fibroid, is actively recruiting participants, sponsored by InSightec.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Primary Outcome
All adverse events and/or serious adverse events will be documented and reported according to protocol.
Conditions Studied
Interventions
- DEVICE Body System - Functional
Study Locations (6)
Other
- Huashan Hospital Affiliated to Fudan University - Shanghai
- Shanghai No. 1 Hospital - Shanghai
- Shanghai No.1 Hospital - Shanghai
California
- UCLA - Los Angeles
- Stanford University - Stanford
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-02-16 |
| Est. Completion | 2026-12-31 |
What NCT05386615 shows while recruiting
NCT05386615 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 282-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Uterine Fibroid appearing as the primary indexed condition, and to 1 intervention - of which Body System - Functional is the first listed.
NCT05386615 lists 6 locations in 3 states (Other, California, Minnesota).
Frequently Asked Questions
What is clinical trial NCT05386615 about?
NCT05386615 is a clinical study titled "Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids". The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
What is the current status of trial NCT05386615?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2016-02-16. Estimated completion is 2026-12-31.
What conditions does trial NCT05386615 study?
This clinical trial studies the following conditions: Uterine Fibroid.
What interventions are being tested in trial NCT05386615?
The interventions under investigation include: Body System - Functional (DEVICE).
Who is sponsoring clinical trial NCT05386615?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05386615 being conducted?
This trial has 6 study locations across California, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
RECRUITING · Phase 2
-
Life Study: Lifestyle Intervention in Fibroid Elimination
ACTIVE NOT RECRUITING · NA
-
Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings
COMPLETED · NA
-
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
COMPLETED · Phase 3
-
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI